Navigation

  • Feed aggregator
    • Sources
logo

Search

Primary links

  • HOME
  • ABOUT US
    • Emerging Markets
  • services
    • Country & Site Selection
    • Regulatory
    • Site management
    • Clinical Monitoring
    • Medical Monitoring
    • Quality Assurance & Audits
    • Medical Translations
    • Trial Performance
  • Therapeutic Experience
  • countries
  • Patients & Sites
  • case studies
    • Cardiovascular Rescue
    • Atrial Fibrillation
    • Breast Cancer
  • contact

Sources

World Pharma News

  • Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders 2 weeks 5 days old
  • A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy 2 weeks 6 days old
  • Common gout drug may reduce risk of heart attack and stroke 3 weeks 2 days old
More

Biospace news

  • FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected 1 year 10 hours old
  • Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff 1 year 10 hours old
  • PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices 1 year 10 hours old
More
Syndicate content

World Pharma News

  • Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders
  • A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy
  • Common gout drug may reduce risk of heart attack and stroke
  • New nasal vaccine has potential to transform respiratory disease prevention
  • MIT research finds particles that enhance mRNA delivery could reduce vaccine dosage and costs
more

© 2010 S&P Pharmaterra Management